흰쥐에서 양막 유래 줄기세포가 Lipopolysaccharide 정주에 따른 염증반응에 미치는 영향 = Effect of amnion derived stem cells on inflammatory response in endotoxemic rats

다국어 초록 (Multilingual Abstract)

Background: Systemic inflammatory response syndrome (SIRS) and sepsis are one among the most common causes of death in intensive care units. Tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and interleukin-10 (IL-10) increase during SIRS and sepsis. Recent studies have demonstrated that amnion derived stem cells have anti-inflammatory effects, low immunogenicity and pluripotency. In addition, there is little ethical objection to the use of amnion derived stem cells. Here, the author presents the first study demonstrating the therapeutic potential for the use of amnion derived stem cells in a rat model of SIRS and sepsis.
Methods: Amnion derived stem cells were isolated from amnion obtained from an uncomplicated Cesarean section and cultured. SIRS and sepsis were induced in rats by lipopolysacchride (15 mg/kg, LPS), and amnion derived stem cells were then transplanted intravenously. The heart rate, mean arterial pressure and the concentration of TNF-α, IL-6 and IL-10 were assessed at baseline and 2 hours and 4 hours after procedure.
Results: The changes of heart rate and mean arterial pressure were reduced in the amnion derived stem cells transplanted group. In addition, increases in the plasma concentration of TNF-α, IL-6 and IL-10 were attenuated in the amnion derived stem cells transplanted group.
Conclusions: This study demonstrated that amnion derived stem cells attenuate inflammatory response during SIRS and sepsis. Transplantation of amnion derived stem cells can be a novel cell based therapeutic strategy for SIRS and sepsis.

다국어 초록 (Multilingual Abstract)

Background: Systemic inflammatory response syndrome (SIRS) and sepsis are one among the most common causes of death in intensive care units. Tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and interleukin-10 (IL-10) increase during SIRS and sepsis. Recent studies have demonstrated that amnion derived stem cells have anti-inflammatory effects, low immunogenicity and pluripotency. In addition, there is little ethical objection to the use of amnion derived stem cells. Here, the author presents the first study demonstrating the therapeutic potential for the use of amnion derived stem cells in a rat model of SIRS and sepsis.
Methods: Amnion derived stem cells were isolated from amnion obtained from an uncomplicated Cesarean section and cultured. SIRS and sepsis were induced in rats by lipopolysacchride (15 mg/kg, LPS), and amnion derived stem cells were then transplanted intravenously. The heart rate, mean arterial pressure and the concentration of TNF-α, IL-6 and IL-10 were assessed at baseline and 2 hours and 4 hours after procedure.
Results: The changes of heart rate and mean arterial pressure were reduced in the amnion derived stem cells transplanted group. In addition, increases in the plasma concentration of TNF-α, IL-6 and IL-10 were attenuated in the amnion derived stem cells transplanted group.
Conclusions: This study demonstrated that amnion derived stem cells attenuate inflammatory response during SIRS and sepsis. Transplantation of amnion derived stem cells can be a novel cell based therapeutic strategy for SIRS and sepsis.

참고문헌 (Reference)

1 Girardin E, "Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura" 319 : 397-400, 1988

2 Kamiya K, "Topical application of culture supernatant from human amniotic epithelial cells suppresses inflammatory reactions in cornea" 80 : 671-679, 2005

3 Langer R, "Tissue engineering" 260 : 920-926, 1993

4 Imagawa DK, "The role of tumor necrosis factor in allograft rejection. III. Evidence that anti-TNF antibody therapy prolongs allograft survival in rats with acute rejection" 51 : 57-62, 1991

5 Tseng SCG, "Suppression of transforming growth factor-beta isoforms, TGF-receptor type II, and myofibroblast differentiation in cultured human corneal and limbal fibroblasts by amniotic membrane matrix" 179 : 325-335, 1999

6 Solomon A, "Suppression of interleukin 1 (alpha) and interleukin 1 (beta) in human limbal epithelial cells cultured on the amniotic membrane stromal matrix" 85 : 444-449, 2001

7 Miki T, "Stem cell characteristics of amniotic epithelial cells" 23 : 1549-1559, 2005

8 Miki T, "Stem cell characteristics of amniotic epithelial cells" 23 : 1549-1559, 2005

9 Wakabayashi G, "Staphylococcus epidermidis induces complement activation, tumor necrosis factor and interleukin-1, a shock-like state and tissue injury in rabbits without endotoxemia: comparison to Escherichia coli" 87 : 1925-1935, 1991

10 Tracey KJ, "Shock and tissue injury induced by recombinant human cachectin" 234 : 470-474, 1986

11 Forfia PR, "Relationship between plasma NOx and cardiac and vascular dysfunction after LPS injection in anesthetized dogs" 274 : 193-201, 1998

12 Dombrovskiy VY, "Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003" 35 : 1414-1415, 2007

13 Waiser J, "Interleukin-6 expression after renal transplantation" 12 : 753-759, 1997

14 Minghini A, "Interleukin-1 and interleukin-6 mediated skeletal muscle arteriolar vasodilation: in vitro versus in vivo studies" 9 : 210-221, 1998

15 Gérard C, "Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia" 177 : 547-550, 1993

16 Li H, "Immunosuppressive factors secreted by human amniotic epithelial cells" 46 : 900-907, 2005

17 Kubo M, "Immunogenicity of human amniotic membrane in experimental xenotransplantation" 42 : 1539-1546, 2001

18 Akle CA, "Immunogenicity of human amniotic epithelial cells after transplantation into volunteers" 2 : 1003-1005, 1981

19 Hao Y, "Identification of antiangiogenic and antiinflammatory proteins in human amniotic membrane" 19 : 348-352, 2000

20 Takashima S, "Human amniotic epithelial cells possess hepatocyte-like characteristics and functions" 29 : 73-84, 2004

21 Wei JP, "Human amnion-isolated cells normalize blood glucose in streptozotocin-induced diabetic mice" 12 : 545-552, 2003

22 Wei JP, "Human amnion-isolated cells normalize blood glucose in streptozotocin-induced diabetic mice" 12 : 545-552, 2003

23 Sakuragawa N, "Human amnion mesenchyme cells express phenotypes of neuroglial progenitor cells" 78 : 208-214, 2004

24 Adinolfi M, "Expression of HLA antigens, beta 2-microglobulin and enzymes by human amniotic epithelial cells" 295 : 325-327, 1982

25 Natanson C, "Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock" 169 : 823-832, 1989

26 Bone RC, "Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine" 101 : 1644-1655, 1992

27 Friedman G, "Blood interleukin 10 levels parallel the severity of septic shock" 12 : 183-187, 1997

28 Scumpia PO, "Biology of interleukin-10 and its regulatory roles in sepsis syndromes" 33 : 468-471, 2005

29 Runic R, "Apoptosis and Fas expression in human fetal membranes" 83 : 660-666, 1998

30 Hammer A, "Amnion epithelial cells, in contrast to trophoblast cells, express all classical HLA class I molecules together with HLA-G" 37 : 161-171, 1997